Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 13Unknown 3Terminated 2

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Hematologic Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Leukemia 1

Interventions

Cytarabine 102Cyclophosphamide 74fludarabine 45Idarubicin 39Decitabine 36Etoposide 35Azacitidine 34Methotrexate 31Daunorubicin 30Vincristine 28Dexamethasone 27venetoclax 25Busulfan 24Imatinib Mesylate 23Radiotherapy 20Mercaptopurine 20Granulocyte Colony-Stimulating Factor 20Dasatinib 19Peripheral Blood Stem Cell Transplantation 18Mitoxantrone 17Doxorubicin 17Immunotherapy, Adoptive 16Rituximab 15Asparaginase 15Tretinoin 14Cladribine 14fludarabine phosphate 13Prednisone 13Prednisolone 13Melphalan 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Voriconazole × Other hematologic neoplasm × Clear all
NCT04743544 2021-02-08

Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy

Dokuz Eylul University

Unknown
62 enrolled
Other hematologic neoplasm

Hematologic Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT04547335 2020-09-16

The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole

Dokuz Eylul University

Unknown
34 enrolled
Other hematologic neoplasm

Hematologic Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT01501708 2016-05-10

Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection

Shanghai Jiao Tong University School of Medicine

Phase 2 Unknown
55 enrolled
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡